Dakota Wealth Management Sells 220 Shares of Colgate-Palmolive (NYSE:CL)

Dakota Wealth Management reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 2.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,714 shares of the company’s stock after selling 220 shares during the quarter. Dakota Wealth Management’s holdings in Colgate-Palmolive were worth $792,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Atomi Financial Group Inc. boosted its stake in shares of Colgate-Palmolive by 6.5% during the fourth quarter. Atomi Financial Group Inc. now owns 6,489 shares of the company’s stock valued at $590,000 after purchasing an additional 394 shares during the period. Crossmark Global Holdings Inc. grew its holdings in Colgate-Palmolive by 4.3% in the 4th quarter. Crossmark Global Holdings Inc. now owns 173,831 shares of the company’s stock worth $15,803,000 after acquiring an additional 7,105 shares during the last quarter. Ballentine Partners LLC increased its position in shares of Colgate-Palmolive by 2.2% in the fourth quarter. Ballentine Partners LLC now owns 21,007 shares of the company’s stock valued at $1,910,000 after acquiring an additional 460 shares during the period. ZWJ Investment Counsel Inc. raised its stake in shares of Colgate-Palmolive by 11.1% during the fourth quarter. ZWJ Investment Counsel Inc. now owns 3,881 shares of the company’s stock valued at $353,000 after acquiring an additional 388 shares during the last quarter. Finally, Koshinski Asset Management Inc. boosted its holdings in shares of Colgate-Palmolive by 7.2% during the fourth quarter. Koshinski Asset Management Inc. now owns 8,292 shares of the company’s stock worth $754,000 after purchasing an additional 558 shares during the period. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. UBS Group reduced their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday, January 17th. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Finally, StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $101.11.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Down 0.0 %

Shares of Colgate-Palmolive stock opened at $87.88 on Friday. The company has a 50-day simple moving average of $91.93 and a two-hundred day simple moving average of $97.51. Colgate-Palmolive has a 52-week low of $80.03 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock has a market capitalization of $71.79 billion, a PE ratio of 25.18, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.